Assessment of solvent effects on the inclusion behavior of pyrazinamide drug into cyclic peptide based nanotubes as novel drug delivery vehicles

Computer-aided nanodrug discovery: recent progress and future prospects

Nanodrugs, which utilise nanomaterials in disease prevention and therapy, have attracted considerable interest since their initial conceptualisation in the 1990s. Substantial efforts have been made to develop nanodrugs for overcoming the limitations of conventional drugs, such as low targeting efficacy, high dosage and toxicity, and potential drug resistance. Despite the significant progress that has been made in nanodrug discovery, the precise design or screening of nanomaterials with desired biomedical functions prior to experimentation remains a significant challenge. This is particularly the case with regard to personalised precision nanodrugs, which require the simultaneous optimisation of the structures, compositions, and surface functionalities of nanodrugs. The development of powerful computer clusters and algorithms has made it possible to overcome this challenge through in silico methods, which provide a comprehensive understanding of the medical functions of nanodrugs in relation to their physicochemical properties. In addition, machine learning techniques have been widely employed in nanodrug research, significantly accelerating the understanding of bio-nano interactions and the development of nanodrugs. This review will present a summary of the computational advances in nanodrug discovery, focusing on the understanding of how the key interfacial interactions, namely, surface adsorption, supramolecular recognition, surface catalysis, and chemical conversion, affect the therapeutic efficacy of nanodrugs. Furthermore, this review will discuss the challenges and opportunities in computer-aided nanodrug discovery, with particular emphasis on the integrated "computation + machine learning + experimentation" strategy that can potentially accelerate the discovery of precision nanodrugs.

Protein Nanotubes as Advanced Material Platforms and Delivery Systems

Protein nanotubes (PNTs) as state-of-the-art nanocarriers are promising for various potential applications both in the food and pharmaceutical industries. Derived from edible starting sources like α-lactalbumin, lysozyme, and ovalbumin, PNTs bear properties of biocompatibility and biodegradability. Their large specific surface area and hydrophobic core facilitate chemical modification and loading of bioactive substances, respectively. Moreover, their enhanced permeability and penetration ability across biological barriers such as intestinal mucus, extracellular matrix, and thrombus clot, make it promising platforms for health-related applications. Most importantly, their simple preparation processes enable large-scale production, supporting applications in the biomedical and nanotechnological fields. Understanding the self-assembly principles is crucial for controlling their morphology, size, and shape, and thus provides the ground to a multitude of applications. Here, the current state-of-the-art of PNTs including their building materials, physicochemical properties, and self-assembly mechanisms are comprehensively reviewed. The advantages and limitations, as well as challenges and prospects for their successful applications in biomaterial and pharmaceutical sectors are then discussed and highlighted. Potential cytotoxicity of PNTs and the need of regulations as critical factors for enabling in vivo applications are also highlighted. In the end, a brief summary and future prospects for PNTs as advanced platforms and delivery systems are included.

Hydrogen-Bond-Driven Peptide Nanotube Formation: A DFT Study

DFT calculations were carried out to examine geometries and binding energies of H-bond-driven peptide nanotubes. A bolaamphiphile molecule, consisting of two N-α amido glycylglycine head groups linked by either one CH2 group or seven CH2 groups, is used as a building block for nanotube self-assembly. In addition to hydrogen bonds between adjacent carboxy or amide groups, nanotube formation is also driven by weak C-H· · ·O hydrogen bonds between a methylene group and the carboxy OH group, and between a methylene group and an amide O=C group. The intratubular O-H· · ·O=C hydrogen bonds account for approximately a third of the binding energies. Binding energies calculated with the wB97XD/DGDZVP method show that the hydrocarbon chains play a stabilizing role in nanotube self-assembly. The shortest nanotube has the length of a single monomer and a diameter than increases with the number of monomers. Lengthening of the tubular structure occurs through intertubular O-H· · ·O=C hydrogen bonds. The average intertubular O-H· · ·O=C hydrogen bond binding energy is estimated to change with the size of the nanotubes, decreasing slightly towards some plateau value near 15 kcal/mol according to the wB97XD/DGDZVP method.

Cyclotide Nanotubes as a Novel Potential Drug-Delivery System: Characterization and Biocompatibility

Cyclotides are a class of cyclic peptides that can be self-assembled. This study aimed to discover the properties of cyclotide nanotubes. We performed differential scanning calorimetric (DSC) to characterize their properties. Then, we incorporated the coumarin as a probe and identified the morphology of nanostructures. The stability of cyclotide nanotubes after 3 months of keeping at -20 °C was determined by field emission scanning electron microscopy (FESEM). The cytocompatibility of cyclotide nanotubes was evaluated on peripheral blood mononuclear cells. In vivo, studies were also conducted on female C57BL/6 mice by intraperitoneally administration of nanotubes at 5, 50, and 100 mg/kg doses. Blood sampling was done before and 24 h after nanotube administration and complete blood count tests were conducted. DSC thermogram showed that the cyclotide nanotubes were stable after heating until 200 °C. Fluorescence microscopy images proved that the self-assembled structures of cyclotide can encapsulate the coumarin. FESEM proved that these nanotubes were stable even after 3 months. The results of the cytotoxicity assay and in-vivo study confirmed that these novel prepared nanotubes were biocompatible. These results suggested that the cyclotide nanotubes could be considered as a new carrier in biological fields while they are biocompatible.

New insights into Hexakis macrocycles as a novel nano-carrier for highly potent anti-cancer treatment: A new challenge in drug delivery

The purpose of this study is to design and evaluate a new tubular assembly structure of Hexakis (m-phenylene ethynylene) (m-PE) macrocycles and to explore its potential application as an innovative drug delivery system. First, we focused on how (m-PE) macrocycles can be self-assembled in both chloroform (CHCl₃) and water solvents for the formation of the assembled nanotube using molecular dynamics (MD) simulations. In contrast to their behavior in water solvent, all ten (m-PE) macrocycles remain aggregated at low concentrations of CHCl₃. We found that these macrocycles carrying chiral side chains and capable of H-bonded self-association, assemble into tubular stacks. Then, the dual delivery strategy for the transport of doxorubicin (DOX) and curcumin (Cur) on the self-assembly system of hexakis (m-PE) nanocarrier is examined using molecular dynamics (MD) simulation and free energy calculation. The obtained results indicated that the binding energy of DOX (- 298.9 kJ/mol) on hexakis (m-PE) in the presence of Cur is higher than free DOX (- 247.7 kJ/mol). Furthermore, in the interaction of the DOX and hexakis m-PE, the contribution of van der Walls (vdW) energy is higher than electrostatic (elec) energy, which can be related to the strong π-π interactions between the drug molecules with the carrier surface. In general, the results indicated that the simultaneous delivery of DOX and Cur through DOX/Cur/hexakis (m-PE) could be a promising vehicle in tumor therapy. Based on the obtained results of the present research, hexakis (m-PE) macrocycle can be used as a drug delivery vehicle for targeted or systemic delivery.

Comparison between gelatin/carboxymethyl cellulose and gelatin/carboxymethyl nanocellulose in tramadol drug loaded capsule

The comparison between Tramadol drug loaded microspheres prepared from gelatin/sodium carboxymethyl cellulose (NaCMC) and those prepared from gelatin/sodium carboxymethyl nanocellulose (NaCMNC) in presence of glutaraldehyde (GA) as cross linker was carried out. Cellulose isolated from rice straw was hydrolyzed using 65% H₂SO₄ to prepare nanoparticles with average particle size ranging from 44 to 66 nm. Various formulations of gelatin/NaCMC and gelatin/NACMNC were prepared with different ratios of amounts of gelatin, NaCMC/NaCMNC, and GA. Microspheres were characterized by fourier transform infrared (FTIR) spectroscopy and scanning electron microscopy. The FTIR spectroscopy results confirmed the structure of microsphere and the absence of chemical interactions among Tramadol drug, polymer, and crosslinking agent. The ultraviolet spectroscopy showed 68% efficiency of the drug encapsulation using cellulose, while 55% for nanocellulose. The equilibrium water uptake decreased from 646 to 329% for cellulose microspheres, when the amount of GA increased from 5 to 10 mL. In contrast, the equilibrium water uptake decreased significantly from 501 to 33.7% for nanocellulose microspheres. The yield percentage enhanced from 54.67 to 80% for nanocellulose microspheres. The in vitro release rate was also calculated. The percent cumulative release of drug was significantly increased at the first 2 h and then a slow increase was further noticed. In general, the nanocellulose microsphere showed lower release rates than cellulose. None of the prepared microsphere presented 100% drug release until 12 h.

Theoretical investigation insights into the temperature triggered tegafur anticancer drug release from the surface of graphene oxide nanosheet

In order to quantitatively account of tegafur drug interaction with graphene oxide nanosheet, various geometrical structures are examined to study the detailed effects of drug adsorption on the structural properties, interaction energy and charge transfer of the studied complexes at the microscopic level using the density functional theory study. The bond paths at the quantum theory of atoms in molecules' bond critical points show that the considered complexes are stabilized by the O…H hydrogen bond intermolecular interactions. In addition, the molecular dynamics simulations are applied to simulate drug release in response to the temperature change in the physiological pH. The increasing the temperature of the simulation system from 310 to 315 K has the effect of decreasing the strength of intermolecular attraction and subsequently, liberation of the adsorbed drugs from the surface of the nanosheet is observed.Communicated by Ramaswamy H. Sarma.

Protein nanotubes as state-of-the-art nanocarriers: Synthesis methods, simulation and applications

Application of food proteins as a tool to form nanostructures (especially nanotubular shapes) has been an interesting topic for both the food and pharmaceutical sectors. Organic and protein nanostructures have better biocompatibility and biodegradability compared to inorganic counterparts like carbon nanotubes; in addition, they can undergo surface modifications. Several organic nanotubes have been developed, meanwhile, the engineered protein nanotubes in the food science have been prepared from α-lactalbumin, ovalbumin, cyclic peptide nanotubes, collagen, bovine serum albumin, lysozyme and hydrophobins which are of great interest to be applied in the food industry considering their outstanding properties. This revision underlines the production of protein nanotubular structures and their applications as well as introducing the in silico studies which is a novel field in predicting the interactions of proteins with different molecules before running experimental tests and finally exploring the safety of protein nanotubes. Protein nanotubes have several advantages over other morphologies, such as the functionalizing ability of both the outer and inner layers, enabling an efficient delivery and controlled release and their ability as gelling agents. Also, regarding their natural source in foods, they are promising alternatives to carbon nanotubes.

Comparative prediction of binding affinity of Hydroxyurea anti-cancer to boron nitride and carbon nanotubes as smart targeted drug delivery vehicles

In this study, the adsorption of Hydroxyurea (HU) onto the inner and outer surfaces of boron nitride and carbon nanotubes (CNTs) was investigated using the density functional theory calculations and molecular dynamics (MDs) simulations in aqueous solution. The values of the adsorption energy show that HU molecule is preferentially adsorbed inside of boron nitride and CNTs with the molecular axis parallel to the tubes axis, which means that the cavity of nanotubes is favorable for encapsulation of this drug. Also, it was found that the HU/boron nitride nanotube (BNNT) system is more stable than the HU/CNT system. The stability of the complexes of HU/ BNNT attributed to the formation of the intermolecular hydrogen bonds between the H atoms of HU molecule and the N atoms of BNNT, which is confirmed by Bader's quantum theory of atoms in molecules. The natural bond orbital analysis shows the charge transfers occur from HU molecule to nanotubes in all complexes. Moreover, the adsorption of HU molecule on the surfaces of the nanotubes was investigated by explicit water models. Also, the adsorption behavior of HU on the functionalized boron nitride and CNTs is investigated to design and develop new nanocarriers for biomedical applications. Furthermore, MDs simulations are examined in the presence of one and two drug molecules. The obtained results illustrate that the lowest value of Lennard-Jones (L-J) energy between drug and nanotubes exist in the simulation system with two drug molecules.